Page 23 - எலும்பியல் மருத்துவ பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering News provided by Share this article Share this article RARITAN, N.J., Jan. 27, 2021 /PRNewswire/ Ortho Clinical Diagnostics Holdings plc ( Ortho ), the world s largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the pricing of its initial public offering of 76 million ordinary shares at $17.00 per share. The gross proceeds raised from this offering are expected to be $1,292 million. Ortho s ordinary shares are expected to begin trading on The Nasdaq Global Select Market on January 28, 2021, under the symbol OCDX, and the offering is expected to close on February 1, 2021, subject to customary closing conditions.

New yorkUnited statesPiper sandlerMorgan stanleyBroadridge financial solutionsJp morgan securitiesCredit suisseInvestment bankExchange commissionProspectus departmentGoldman sachs coRamirez co incHc wainwright coPrnewswire ortho clinical diagnostics holdingsClinical diagnostics holdingsNasdaq global select market